{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:32:48Z","timestamp":1789947168430,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vichows Archiv A Pathol Anat"],"published-print":{"date-parts":[[1989]]},"DOI":"10.1007\/bf00724905","type":"journal-article","created":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T08:21:08Z","timestamp":1101975668000},"page":"191-202","source":"Crossref","is-referenced-by-count":43,"title":["Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis\/-sclerosis (agnogenic myeloid metaplasia) - correlations between clinical and morphological features"],"prefix":"10.1007","volume":"415","author":[{"given":"Juergen","family":"Thiele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Hoeppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Zankovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(84)92346-8","volume":"I","author":"Ph Arlet","year":"1984","unstructured":"Arlet Ph, Nicodeme R, Adoue D, Larregain-Fournier D, Delsol G, Le Tallec Y (1984) Clinical evidence for 1,25-hydroxy-cholecalciferol action in myelofibrosis. Lancet I:1013?1014","journal-title":"Lancet"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2141.1979.tb03697.x","volume":"42","author":"SA Bentley","year":"1979","unstructured":"Bentley SA, Herman CJ (1979) Bone marrow fibre production in myelofibrosis: a quantitative study. Br J Haematol 42:51?59","journal-title":"Br J Haematol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0344-0338(84)80124-7","volume":"1","author":"R Burkhardt","year":"1984","unstructured":"Burkhardt R, Bartl R, J\u00e4ger K, Frisch B, Kettner B, Mahl G, Sund M (1984) Chronic myeloproliferative disorders (CMPD). Pathol Res Pract 1:131?1868","journal-title":"Pathol Res Pract"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jcp.39.3.237","volume":"39","author":"R Burkhardt","year":"1986","unstructured":"Burkhardt R, Bart R, J\u00f6ger K, Frisch B, Kettner B, Mahl G, Sund M (1986) Working classification of chronic myeloproliferative disorders based on histological, haematological and clinical findings. J Clin Pathol 39:237?252","journal-title":"J Clin Pathol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2141.1984.tb02912.x","volume":"57","author":"SA Burstein","year":"1984","unstructured":"Burstein SA, Malpass TW, Yee E, Kadin M, Bridgen M, Adamson JW, Harker LA (1984) Platelet factor 4-excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. Br J Haematol 57:383?392","journal-title":"Br J Haematol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2141.1981.tb07192.x","volume":"49","author":"F Caligaris Cappio","year":"1981","unstructured":"Caligaris Cappio F, Vigliani R, Novarino A, Camussi G, Campagna G, Gavosto F (1981) Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 49:17?21","journal-title":"Br J Haematol"},{"key":"CR7","first-page":"427","volume-title":"Myelofibrosis and the biology of connective tissue","author":"H Castro-Malaspina","year":"1984","unstructured":"Castro-Malaspina H (1984) Pathogenesis of myelofibrosis: role of ineffective megakaryopoioesis and megakaryocytic components. In: Berk P, Castro-Malaspina H, Wasserman L (eds) Myelofibrosis and the biology of connective tissue. AR Liss, New York, pp 427?454"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood.V57.4.781.781","volume":"57","author":"H Castro-Malaspina","year":"1981","unstructured":"Castro-Malaspina H, Rabellino M, Yen A, Nachman RL, Moore MAS (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57:781?787","journal-title":"Blood"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.1979.tb01164.x","volume":"42","author":"V Clough","year":"1979","unstructured":"Clough V, Geary CG, Hashmi K, Davson J, Knowlson T (1979) Myelofibrosis in chronic granulocytic leukaemia. Br J Haematol 42:515?526","journal-title":"Br J Haematol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","volume":"6","author":"W Dameshek","year":"1951","unstructured":"Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372?375","journal-title":"Blood"},{"key":"CR11","first-page":"1625","volume":"50","author":"C Devred","year":"1974","unstructured":"Devred C, Diebold J (1974) La myelofibrose au cours des hematopathies. Valeur diagnostique et prognostique. A propos de 402 observations. Sem Hop Paris 50:1625?1634","journal-title":"Sem Hop Paris"},{"key":"CR12","first-page":"209","volume":"10","author":"G Duhamel","year":"1970","unstructured":"Duhamel G, Najman, Andre R (1970) L'histologie de la moelle osseuse dans la maladie de Vaquez et le probleme de la myelosclerose a propos de 70 biopsies. Nouv Rev Franc Hematol 10:209?222","journal-title":"Nouv Rev Franc Hematol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.1987.tb01348.x","volume":"66","author":"AS Duncombe","year":"1987","unstructured":"Duncombe AS, Pearson TC, Nunan TO, Miller A, McCarthy DM (1987) 1,25 dihydroxyvitamin D3 (1,25 vit (OH)2, D3) in the treatment of idiopathic myelofibrosis. Br J Hematol 66:579?580","journal-title":"Br J Hematol"},{"key":"CR14","first-page":"144","volume":"23","author":"JT Ellis","year":"1986","unstructured":"Ellis JT, Perterson P, Geller SA, Rappaport H (1986) Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol 23:144?155","journal-title":"Semin Hematol"},{"key":"CR15","volume-title":"Statistical methods for research workers","author":"RA Fisher","year":"1972","unstructured":"Fisher RA (1972) Statistical methods for research workers. Oliver & Boyd, Edinburgh"},{"key":"CR16","first-page":"51","volume-title":"Myelofibrosis. Pathophysiology and clinical management","author":"B Frisch","year":"1985","unstructured":"Frisch B, Bartl R (1985) Histology of myelofibrosis and osteomyelosclerosis. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 51?86"},{"key":"CR17","first-page":"57","volume":"50","author":"B Frisch","year":"1984","unstructured":"Frisch B, Bartl R, Burkhardt R, J\u00e4ger K, Mahl G, Kettner G (1984) Classification of myeloproliferative disorders by bone marrow histology. Bibl Haematol (Basel) 50:57?80","journal-title":"Bibl Haematol (Basel)"},{"key":"CR18","first-page":"467","volume":"154","author":"SM Fruchtman","year":"1984","unstructured":"Fruchtman SM (1984) Therapeutic implications of the collagen metabolism in myelofibrosis. Prog Clin Biol Res 154:467?474","journal-title":"Prog Clin Biol Res"},{"key":"CR19","first-page":"15","volume-title":"Myelofibrosis. Pathophysiology and clinical management","author":"CG Geary","year":"1985","unstructured":"Geary CG (1985) Clinical and hematological aspects of chronic myelofibrosis. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 15?49"},{"key":"CR20","first-page":"41","volume":"50","author":"A Georgii","year":"1984","unstructured":"Georgii A, Vykoupil KF, Thiele J (1984a) Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course. Bibl Haematol (Basel) 50:41?56","journal-title":"Bibl Haematol (Basel)"},{"key":"CR21","first-page":"147","volume-title":"Pathology of the bone marrow","author":"A Georgii","year":"1984","unstructured":"Georgii A, Vykoupil KF, Thiele J (1984b) Histopathology of bone marrow and clinical findings in chronic myeloproliferative disorders. In: Lennert K and H\u00fcbner K (eds) Pathology of the bone marrow. Gustav Fischer Verlag, Stuttgart New York, pp 147?169"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0025-7125(16)32287-8","volume":"57","author":"HS Gilbert","year":"1973","unstructured":"Gilbert HS (1973) The spectrum of myeloproliferative disorders. Med Clin North Am 57:355?393","journal-title":"Med Clin North Am"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.V58.5.904.904","volume":"58","author":"BR Gordon","year":"1981","unstructured":"Gordon BR, Coleman M, Kohen P, Day NK (1981) Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood 58:904?910","journal-title":"Blood"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2141.1987.tb01332.x","volume":"66","author":"BR Greenberg","year":"1987","unstructured":"Greenberg BR, Woo L, Veomett IC, Payne CM, Ahmann FR (1987) Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. Br J Haematol 66:487?490","journal-title":"Br J Haematol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","volume":"51","author":"RJ Jacobson","year":"1978","unstructured":"Jacobson RJ, Salo A, Fialkow PJ (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189?194","journal-title":"Blood"},{"key":"CR26","first-page":"335","volume":"77","author":"K Jamshidi","year":"1971","unstructured":"Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture: a new biopsy device. J Lab Clin Med 77:335?342","journal-title":"J Lab Clin Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V53.6.1043.1043","volume":"53","author":"KL Kaplan","year":"1979","unstructured":"Kaplan KL, Chao FC, Stiles CD, Antoniades HN, Scher CD (1979) Platelet alpha-granules contain a growth factor for fibroblasts. Blood 53:1043?1052","journal-title":"Blood"},{"key":"CR28","first-page":"409","volume":"12","author":"J Laszlo","year":"1975","unstructured":"Laszlo J (1975) Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 12:409?432","journal-title":"Semin Hematol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1986.tb04115.x","volume":"64","author":"M Lazzarino","year":"1986","unstructured":"Lazzarino M, Morra E, Castello A, Inveradi D, Coci A, Pagnucco G, Magrini U, Zei G, Bernasconi C (1986) Myelofibrosis in chronic granulocytic leukemia: clinicopathologic correlations and prognostic significance. Br J Hematol 64:227?240","journal-title":"Br J Hematol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0308-2261(21)00079-5","volume":"4","author":"K Lennert","year":"1975","unstructured":"Lennert K, Nagai K, Schwarze E-W (1975) Patho-anatomical features of the bone marrow. Clin Hematol 4:331?351","journal-title":"Clin Hematol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2141.1978.tb01093.x","volume":"39","author":"CM Lewis","year":"1978","unstructured":"Lewis CM, Pegrum GD (1978) Immune complexes in myelofibrosis: a possible guide to management. Br J Haematol 39:233?239","journal-title":"Br J Haematol"},{"key":"CR32","first-page":"1","volume-title":"Myelofibrosis. Pathophysiology and clinical management","author":"SM Lewis","year":"1985","unstructured":"Lewis SM (1985) Myelofibrosis: Historical perspective. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 1?13"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(57)90342-X","volume":"22","author":"JW Linman","year":"1957","unstructured":"Linman JW, Bethell FH (1957) Agnogenic myeloid metaplasia. Am J Med 22:107?122","journal-title":"Am J Med"},{"key":"CR34","first-page":"593","volume":"107","author":"TP Lohman","year":"1983","unstructured":"Lohman TP, Beckman EN (1983) Progressive myelofibrosis in agnogenic myeloid metaplasia. Arch Pathol Lab Med 107:593?594","journal-title":"Arch Pathol Lab Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1985.tb02956.x","volume":"59","author":"DM MacCarthy","year":"1985","unstructured":"MacCarthy DM (1985) Fibrosis of the bone marrow: content and causes. Br J Haematol 59:1?7","journal-title":"Br J Haematol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1988.tb02365.x","volume":"69","author":"A Monoharan","year":"1988","unstructured":"Monoharan A (1988) Myelofibrosis: prognostic factors and treatment. Br J Hematol 69:295?298","journal-title":"Br J Hematol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1987.tb02281.x","volume":"64","author":"R Mc Kinley","year":"1987","unstructured":"Mc Kinley R, Kwan YL, Ford D, Lam-Po-Tang PRI, Mason RS, Manoharan A (1987) Clinical and laboratory studies of 1,25 dihydroxycholecalciferol in myelofibrosis. Br J Hematol 64:252?254","journal-title":"Br J Hematol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.1986.tb02219.x","volume":"64","author":"M Petrini","year":"1986","unstructured":"Petrini M, Cecconi N, Azzara A, Ambrogi F, Grassi B (1986) 1,25-dihydroxyvitamin D3 (1,25 (OH)2 vit D3) in the treatment of idiopathic myelofibrosis. Br J Hematol 64:624?625","journal-title":"Br J Hematol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-57-1-73","volume":"57","author":"JA Pitcock","year":"1982","unstructured":"Pitcock JA, Reinard EH, Justus BW, Mendelsohn RS (1982) A clinical and pathological study of seventy cases of myelofibrosis. Ann Intern Med 57:73?84","journal-title":"Ann Intern Med"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.1986.tb02946.x","volume":"62","author":"C Richard","year":"1986","unstructured":"Richard C, Mazorra F, Iriondo A, Mazo E, Bello C, Zubizarete A (1986) The usefulness of 1,25-dihydroxyvitamin D 3 (1,25 (OH)2 vit D 3) in the treatment of idiopathic myelofibrosis. Br J Hematol 62:399?400","journal-title":"Br J Hematol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.1983.tb02048.x","volume":"53","author":"E Rondeau","year":"1983","unstructured":"Rondeau E, Solal-Celigny P, Dhermy D, Vroclans M, Brousse N, Bernard JF, Boivin P (1983) Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol 53:467?475","journal-title":"Br J Haematol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(78)90107-1","volume":"14","author":"R Ross","year":"1978","unstructured":"Ross R, Vogel A (1978) The platelet-derived growth factor. Cell 14:203?210","journal-title":"Cell"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2141.1982.tb01929.x","volume":"50","author":"C Rozman","year":"1982","unstructured":"Rozman C, Vives-Corrons JL, Hernandez-Nieto L, Feliu E, Ester A (1982) Idiopathic myelofibrosis: a possible role of immunological phenomena. Br J Haematol 50:375?376","journal-title":"Br J Haematol"},{"key":"CR44","first-page":"6","volume-title":"Pathology of the bone marrow","author":"HE Schaefer","year":"1984","unstructured":"Schaefer HE (1984) How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K, H\u00fcbner K (eds) Pathology of the bone marrow. Gustav Fischer Verlag, Stuttgart New York, pp 6?9"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00996082","volume":"34","author":"HE Schaefer","year":"1977","unstructured":"Schaefer HE Hellriegel KP, Fischer R (1977) Vorkommen von tartratresistenter saurer Phosphatase in verschiedenen Zelltypen des lymphoreticul\u00e4ren und h\u00e4matopoetischen Zellsystems. Blut 34:393?397","journal-title":"Blut"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archinte.1974.00320190115016","volume":"134","author":"MN Silverstein","year":"1974","unstructured":"Silverstein MN (1974) Postpolycythemia myeloid metaplasia. Arch Intern Med 134:113?115","journal-title":"Arch Intern Med"},{"key":"CR47","unstructured":"Silverstein MN (1975) Agnogenic myeloid metaplasia. Publishing Science Group, Acton, Mass"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03003181","volume":"5","author":"J Thiele","year":"1988","unstructured":"Thiele J, Thienel C, Zankovich R, Fischer R (1988) Prognostic features at diagnosis of chronic myeloid leukemia with special emphasis on histological parameters. Med Oncol Tumor Pharmacother 5:49?60","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0344-0338(88)80090-6","volume":"183","author":"J Thiele","year":"1988","unstructured":"Thiele J, Simon K-G, Fischer R, Zankovich R (1988) Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukemia and so-called primary (idiopathic) osteomyelofibrosis. Evolution of histopathological lesions and clinical courses in 40 patients. Pathol Res Pract 183:434?445","journal-title":"Pathol Res Pract"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-197109000-00001","volume":"50","author":"HP Ward","year":"1971","unstructured":"Ward HP, Block MH (1971) The natural history of agnogenic myeloid metaplasia. Medicine 50:357?420","journal-title":"Medicine"},{"key":"CR51","first-page":"30","volume":"54","author":"LR Wasserman","year":"1981","unstructured":"Wasserman LR, Balcerak SP, Berk PD (1981) Influence of therapy on causes of death in polycythemia vera. Trans Assoc Am Physiol 54:30?38","journal-title":"Trans Assoc Am Physiol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V65.4.803.803","volume":"65","author":"BC Wolf","year":"1985","unstructured":"Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65:803?809","journal-title":"Blood"},{"key":"CR53","first-page":"77","volume":"1","author":"BC Wolf","year":"1987","unstructured":"Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hem Pathol 1:77?80","journal-title":"Hem Pathol"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ajcp\/80.2.140","volume":"80","author":"BC Wolf","year":"1983","unstructured":"Wolf BC, Luevano E, Neiman RS (1983) Evidence that the human fetal spleen is not a hematopoietic organ. Am J Clin Pathol 80:140?144","journal-title":"Am J Clin Pathol"}],"container-title":["Virchows Archiv A Pathological Anatomy and Histopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00724905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00724905\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00724905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T17:17:23Z","timestamp":1682875043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00724905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989]]}},"alternative-id":["BF00724905"],"URL":"https:\/\/doi.org\/10.1007\/bf00724905","relation":{},"ISSN":["0174-7398","1432-2307"],"issn-type":[{"value":"0174-7398","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989]]}}}